Irreversible electroporation: state of the art
暂无分享,去创建一个
Daniel M de Bruin | Willemien van den Bos | Patricia J Zondervan | D. D. de Bruin | J. J. de la Rosette | P. Zondervan | Mara Buijs | M Pilar Laguna Pes | Peter GK Wagstaff | Jean JMCH de la Rosette | P. Wagstaff | W. van den Bos | M. Buijs | M. L. Laguna Pes | Peter Gk Wagstaff | Jean Jmch De La Rosette | M Pilar | Laguna Pes | Jean de la Rosette | Pilar Laguna | Laguna Pes | Peter Gk Wagstaff | Jean Jmch De La Rosette | M. Pilar | Jean de la Rosette | Jean de la Rosette | Peter Gk Wagstaff | Jean Jmch De La Rosette | M. Pilar
[1] Boris Rubinsky,et al. Tumor Ablation with Irreversible Electroporation , 2007, PloS one.
[2] J. Bruix,et al. Management of hepatocellular carcinoma: An update , 2011, Hepatology.
[3] Samuel K. Park,et al. Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney. , 2013, Urology.
[4] H. Itoh,et al. Electroporation of cell membrane visualized under a pulsed-laser fluorescence microscope. , 1988, Biophysical journal.
[5] G. Kazemier,et al. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study , 2014, European Radiology.
[6] David W. Taggart,et al. No surgical innovation without evaluation: the IDEAL recommendations , 2009, The Lancet.
[7] Amita Sharma,et al. Image-guided ablative therapies for lung cancer. , 2012, Radiologic clinics of North America.
[8] H. Ahmed,et al. INITIAL ASSESSMENT OF SAFETY AND CLINICAL FEASIBILITY OF IRREVERSIBLE ELECTROPORATION IN THE FOCAL TREATMENT OF PROSTATE CANCER , 2014, Prostate Cancer and Prostatic Disease.
[9] Andrea Lodi,et al. Design of an Irreversible Electroporation System for Clinical Use , 2007, Technology in cancer research & treatment.
[10] Daniel M de Bruin,et al. Thermal Energy during Irreversible Electroporation and the Influence of Different Ablation Parameters. , 2016, Journal of vascular and interventional radiology : JVIR.
[11] J. Cadeddu,et al. Minimally Invasive Percutaneous Treatment of Small Renal Tumors with Irreversible Electroporation: A Single-Center Experience. , 2015, Journal of vascular and interventional radiology : JVIR.
[12] Jens Ricke,et al. Irreversible Electroporation of Renal Cell Carcinoma: A First-in-Man Phase I Clinical Study , 2011, CardioVascular and Interventional Radiology.
[13] Yoshiyuki Kobayashi,et al. Irreversible electroporation for nonthermal tumor ablation in patients with hepatocellular carcinoma: initial clinical experience in Japan , 2015, Japanese Journal of Radiology.
[14] Vic Velanovich,et al. Irreversible Electroporation in Locally Advanced Pancreatic Cancer: Potential Improved Overall Survival , 2013, Annals of Surgical Oncology.
[15] E. Neumann,et al. Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.
[16] C. Bassi,et al. Safety and Feasibility of Irreversible Electroporation (IRE) in Patients with Locally Advanced Pancreatic Cancer: Results of a Prospective Study , 2015, Digestive Surgery.
[17] E. Jung,et al. Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: a prospective single-center study. , 2015, Journal of vascular and interventional radiology : JVIR.
[18] Yuman Fong,et al. Ablation of perivascular hepatic malignant tumors with irreversible electroporation. , 2012, Journal of the American College of Surgeons.
[19] T. Reese,et al. Changes in membrane structure induced by electroporation as revealed by rapid-freezing electron microscopy. , 1990, Biophysical journal.
[20] Damijan Miklavčič,et al. Electrochemotherapy: from the drawing board into medical practice , 2014, BioMedical Engineering OnLine.
[21] J. Köllermann,et al. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial , 2016, CardioVascular and Interventional Radiology.
[22] H. Itoh,et al. Membrane conductance of an electroporated cell analyzed by submicrosecond imaging of transmembrane potential. , 1991, Biophysical journal.
[23] V. Shelat,et al. Radiofrequency ablation of pancreatic ductal adenocarcinoma: The past, the present and the future. , 2015, World journal of gastrointestinal oncology.
[24] Oxford Centre for Evidence-based Medicine Levels of Evidence (January 2001) , 2014 .
[25] S. Kee,et al. Electron microscopic demonstration and evaluation of irreversible electroporation-induced nanopores on hepatocyte membranes. , 2012, Journal of vascular and interventional radiology : JVIR.
[26] Boris Rubinsky,et al. Irreversible Electroporation: First Patient Experience Focal Therapy of Prostate Cancer , 2010 .
[27] Stuart K. Roberts,et al. Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience and Review of Safety and Outcomes , 2013, Technology in Cancer Research and Treatment.
[28] S. Chalikonda,et al. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. , 2015, Annals of surgery.
[29] R. Lencioni,et al. Hepatocellular carcinoma: new options for image-guided ablation , 2010, Journal of hepato-biliary-pancreatic sciences.
[30] Thomas Wimmer,et al. Planning Irreversible Electroporation in the Porcine Kidney: Are Numerical Simulations Reliable for Predicting Empiric Ablation Outcomes? , 2015, CardioVascular and Interventional Radiology.
[31] B. Benway. Irreversible Electroporation of Renal Cell Carcinoma: A First-in-Man Phase I Clinical Study: Pech M, Janitzky A, Wendler JJ, et al (Univ of Magdeburg, Germany) Cardiovasc Intervent Radiol 34:132-138, 2011§ , 2011 .
[32] S. Solomon,et al. Percutaneous ablation of peribiliary tumors with irreversible electroporation. , 2014, Journal of vascular and interventional radiology : JVIR.
[33] L. Mir,et al. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. , 1991, European journal of cancer.
[34] John C. Bischof,et al. A Review of Basic to Clinical Studies of Irreversible Electroporation Therapy , 2015, IEEE Transactions on Biomedical Engineering.
[35] Suyashree Bhonsle,et al. Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy , 2015, The Prostate.
[36] Chad R. Tracy,et al. Irreversible electroporation (IRE): a novel method for renal tissue ablation , 2011, BJU international.
[37] Novel methods for renal tissue ablation , 2012, Current opinion in urology.
[38] Boris Rubinsky,et al. Irreversible Electroporation: A New Ablation Modality — Clinical Implications , 2007, Technology in cancer research & treatment.
[39] G. Narayanan,et al. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. , 2012, Journal of vascular and interventional radiology : JVIR.
[40] H. Rhim,et al. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies , 2009, Hepatology.
[41] Martin L. Yarmush,et al. Nonthermal Irreversible Electroporation: Fundamentals, Applications, and Challenges , 2013, IEEE Transactions on Biomedical Engineering.
[42] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[43] Robert C. G. Martin,et al. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures , 2013, Journal of surgical oncology.
[44] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[45] T. Kawabe,et al. Radiofrequency ablation for hepatocellular carcinoma in so‐called high‐risk locations , 2006, Hepatology.
[46] Inderbir S Gill,et al. Contemporary management of small renal masses. , 2011, European urology.
[47] Ton G van Leeuwen,et al. Irreversible electroporation of the porcine kidney: Temperature development and distribution. , 2015, Urologic oncology.
[48] Hessel Wijkstra,et al. The efficacy and safety of irreversible electroporation for the ablation of renal masses: a prospective, human, in-vivo study protocol , 2015, BMC Cancer.
[49] Vic Velanovich,et al. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma. , 2012, Journal of the American College of Surgeons.
[50] Allard C van der Wal,et al. Irreversible electroporation: Just another form of thermal therapy? , 2014, The Prostate.
[51] K. Katsanos,et al. Systematic Review and Meta-Analysis of Thermal Ablation Versus Surgical Nephrectomy for Small Renal Tumours , 2014, CardioVascular and Interventional Radiology.
[52] J. J. de la Rosette,et al. Thermal ablation in renal cell carcinoma management: a comprehensive review , 2014, Current opinion in urology.
[53] G. Andriole. Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer , 2013 .
[54] Boris Rubinsky,et al. In vivo imaging of irreversible electroporation by means of electrical impedance tomography , 2009, Physics in medicine and biology.
[55] P. Scardino,et al. What is still needed to make focal therapy an accepted segment of standard therapy? , 2014, Current opinion in urology.
[56] M. Yeh,et al. Irreversible Electroporation Can Effectively Ablate Hepatocellular Carcinoma to Complete Pathologic Necrosis. , 2015, Journal of vascular and interventional radiology : JVIR.
[57] C. V. van Kuijk,et al. Anaesthetic management during open and percutaneous irreversible electroporation. , 2014, British journal of anaesthesia.
[58] Damijan Miklavčič,et al. Electroporation-based technologies for medicine: principles, applications, and challenges. , 2014, Annual review of biomedical engineering.
[59] Nathan Lawrentschuk,et al. The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review , 2014, European urology.
[60] Helen Kavnoudias,et al. Investigation of the safety of irreversible electroporation in humans. , 2011, Journal of vascular and interventional radiology : JVIR.
[61] C. D. Savci-Heijink,et al. The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients , 2015, World Journal of Urology.